Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-278668
Filing Date
2025-11-13
Accepted
2025-11-13 06:03:20
Documents
14

Document Format Files

Seq Description Document Type Size
1 424B5 d83899d424b5.htm 424B5 775239
2 EX-FILING FEES d83899dexfilingfees.htm   iXBRL EX-FILING FEES 18202
3 GRAPHIC g201599g01a03.jpg GRAPHIC 75039
4 GRAPHIC g83899g01k01.jpg GRAPHIC 49713
  Complete submission text file 0001193125-25-278668.txt   1090261

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT d83899dexfilingfees_htm.xml XML 4741
Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-282032 | Film No.: 251475184
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)